Jeffrey W. Olin

Q: What Schools Are Affiliated With Jeffrey W. Olin

Jeffrey W. Olin is affiliated with the following schools: University of Michigan, Icahn School of Medicine at Mount Sinai, Stanford University, Case Western Reserve University

Jeffrey W. Olin's AcademicInfluence.com Rankings

Jeffrey W. Olin

Philosophy

#8566

World Rank

#11973

Historical Rank

Logic

#5597

World Rank

#7007

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Jeffrey W. Olin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeffrey W. Olin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography (2006) (3207)
Peripheral arterial disease detection, awareness, and treatment in primary care. (2001) (1613)
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care (2001) (1164)
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent (2006) (1040)
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang (2006) (1006)
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017) (987)
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) (640)
2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) (605)
Current concepts: Fibromuscular dysplasia (2004) (576)
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017) (477)
Fibromuscular dysplasia. (2004) (475)
The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients (2012) (448)
Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. (1990) (374)
The Utility of Duplex Ultrasound Scanning of the Renal Arteries for Diagnosing Significant Renal Artery Stenosis (1995) (364)
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. (2014) (351)
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (282)
Thromboangiitis obliterans (Buerger's disease). (2000) (273)
Peripheral artery disease: current insight into the disease and its diagnosis and management. (2010) (272)
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary (2016) (266)
The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). (1990) (244)
Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). (2015) (243)
Diagnosis, management, and future developments of fibromuscular dysplasia. (2011) (230)
Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2°P-TIMI 50 (2013) (219)
Prognostic indicators in venous ulcers. (2000) (215)
Contemporary Management of Postcatheterization Pseudoaneurysms (2007) (211)
Ultrasound-Guided Thrombin Injection for the Treatment of Postcatheterization Pseudoaneurysms (2000) (210)
Use of a Constitutively Active Hypoxia-Inducible Factor-1&agr; Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients: Phase I Dose-Escalation Experience (2007) (189)
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) (2011) (184)
Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure (2002) (182)
Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease (2006) (182)
Preprocedural risk stratification: identifying an appropriate population for carotid stenting. (2001) (175)
Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study (1999) (170)
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. (2000) (167)
High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. (1997) (163)
Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD. (2016) (160)
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. (2004) (158)
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia. (2018) (149)
Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options. (2016) (143)
Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. (2000) (142)
&bgr;2-Microglobulin as a Biomarker in Peripheral Arterial Disease: Proteomic Profiling and Clinical Studies (2007) (140)
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline) (2012) (138)
2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary (2017) (137)
PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance (2016) (136)
Effect of Hypoxia-Inducible Factor-1&agr; Gene Therapy on Walking Performance in Patients With Intermittent Claudication (2011) (131)
First international consensus on the diagnosis and management of fibromuscular dysplasia. (2019) (129)
Fibromuscular dysplasia (2000) (126)
Coronary artery manifestations of fibromuscular dysplasia. (2014) (122)
Thrombolysis of peripheral arterial bypass grafts: surgical thrombectomy compared with thrombolysis. A preliminary report. (1988) (114)
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (2016) (111)
Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. (1991) (107)
Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection. (2019) (106)
First International Consensus on the diagnosis and management of fibromuscular dysplasia (2019) (104)
Ultrasound-guided compression closure of postcatheterization pseudoaneurysms during concurrent anticoagulation: a review of seventy-seven patients. (1996) (102)
Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trials. (2012) (102)
Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies (2012) (102)
Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Anticoagulants or inferior vena cava filter? (1987) (100)
Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on K (2006) (96)
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication (2001) (95)
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. (2003) (90)
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial. (2003) (87)
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. (2007) (83)
ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part I: Arterial Ultrasound and Physiological Testing (2012) (82)
ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Comm (2004) (82)
Pathophysiology of peripheral arterial disease and risk factors for its development. (2006) (79)
Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis (2011) (78)
Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. (1997) (78)
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. (2013) (75)
Contemporary management of fibromuscular dysplasia (2008) (72)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and I (2010) (69)
Thromboangiitis obliterans (Buerger's disease) (2006) (69)
Optimal Treatment of Uncomplicated Type B Aortic Dissection: JACC Review Topic of the Week. (2019) (66)
Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. (1996) (63)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I (2010) (63)
Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial (2003) (63)
Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging. (2004) (63)
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standar (2012) (63)
Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry (2016) (62)
Diagnosis and management of atherosclerotic renal artery stenosis: improving patient selection and outcomes (2009) (61)
Recognizing and managing fibromuscular dysplasia. (2007) (59)
Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). (1999) (58)
Alternative ankle-brachial index method identifies additional at-risk individuals. (2013) (58)
The S curve: A novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia (2012) (56)
High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. (2004) (55)
A biomarker panel for peripheral arterial disease (2008) (53)
The incidence of deep venous thrombosis in patients undergoing abdominal aortic aneurysm resection. (1993) (53)
The natural history of asymptomatic moderate internal carotid artery stenosis by duplex ultrasound (1998) (51)
Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia (2017) (50)
Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication. (2002) (49)
Atherosclerotic renal artery disease. (2002) (47)
Claudication secondary to Perclose use after percutaneous procedures (2006) (47)
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. (2016) (46)
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. (2001) (45)
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. (2018) (43)
Experience with percutaneous transluminal angioplasty for renal artery stenosis at the Cleveland Clinic. (1988) (43)
Low lifetime recreational activity is a risk factor for peripheral arterial disease. (2011) (41)
Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review (2019) (40)
Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? (2008) (40)
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standar (2012) (39)
Noninvasive imaging of the renal arteries. (2001) (39)
Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA‐approved trials (2014) (39)
Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. (1997) (38)
Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. (2009) (37)
Role of duplex ultrasonography in screening for significant renal artery disease. (1994) (37)
Renal artery disease: diagnosis and management. (2004) (37)
Renovascular disease in the elderly: an analysis of 50 patients. (1985) (36)
Acute coronary syndromes without coronary plaque rupture (2016) (36)
Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease. (2020) (34)
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (2016) (34)
Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial. (2016) (34)
Masterclass series in peripheral arterial disease (2005) (33)
Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization (2010) (33)
Peripheral artery disease. Part 2: medical and endovascular treatment (2011) (33)
Fibromuscular Dysplasia: Contemporary Concepts and Future Directions. (2018) (32)
Acute aortic dissection: the need for rapid, accurate, and readily available diagnostic strategies. (2003) (31)
Experience with Endovascular Abdominal Aortic Aneurysm Repair in Nonagenarians (2006) (31)
Smoking and Adverse Outcomes in Fibromuscular Dysplasia: U.S. Registry Report. (2016) (31)
The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up. (2004) (29)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease (2010) (28)
Effect of physical activity assessment on prognostication for peripheral artery disease and mortality. (2015) (28)
Beta 2 Microglobulin as a Biomarker in Peripheral Arterial Disease: Proteomic Profiling and Clinical Studies (2007) (27)
Is fibromuscular dysplasia a single disease? (2012) (27)
Stenting for atherosclerotic renal artery stenosis: One poorly designed trial after another (2010) (27)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I (2011) (26)
Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. (2012) (26)
Safety and efficacy of renal artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospective multicenter registry. (2010) (26)
A Plasma Proteogenomic Signature for Fibromuscular Dysplasia. (2019) (26)
Safety and efficacy of thrombolytic therapy for superior vena cava syndrome (1990) (25)
Anti-platelet and anti-hypertension medication use in patients with fibromuscular dysplasia: Results from the United States Registry for Fibromuscular Dysplasia (2015) (25)
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. (2004) (25)
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and I (2010) (24)
ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS/SVU [corrected] 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation appropriate use criteria task (2012) (24)
Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes (2020) (23)
Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. (2013) (22)
Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases (2021) (21)
Postgraduate training in vascular medicine: proposed requirements and standards (2003) (21)
ACC/ACP/SCAI/SVMB/SVS Clinical Competence statement (2004) (21)
Renal artery duplex ultrasound criteria for the detection of significant in‐stent restenosis (2014) (21)
The Public and the Profession’s Perception of Social Work (2013) (21)
Upper extremity arterial disease. (2002) (20)
Walking Impairment Questionnaire Improves Mortality Risk Prediction Models in a High-Risk Cohort Independent of Peripheral Arterial Disease Status (2013) (20)
Disseminated intravascular coagulation associated with acute ischemic hepatitis after elective aortic aneurysm repair: comparative analysis of 10 cases. (1997) (19)
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy (2004) (19)
Expanding Clinical Phenotype of Fibromuscular Dysplasia. (2017) (19)
Natural History of Cervical Artery Fibromuscular Dysplasia and Associated Neurovascular Events (2016) (18)
Diagnostic utility of carotid artery duplex ultrasonography in the evaluation of syncope: a good test ordered for the wrong reason. (2015) (17)
Clinical and socioeconomic factors associated with unrecognized peripheral artery disease (2014) (17)
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis (2017) (17)
Thromboangiitis Obliterans (Buerger's Disease) (1997) (16)
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial (2020) (16)
Power-pulse spray thrombectomy for treatment of Paget-Schroetter syndrome. (2007) (16)
Carotid endarterectomy in adults 50 years of age and younger: a retrospective comparative study. (1997) (16)
Insights Into Spontaneous Coronary Artery Dissection: Can Recurrence Be Prevented? (2017) (16)
HMG-CoA reductase inhibitors (1988) (15)
US Preventive Services Task Force recommendation statement regarding screening for peripheral artery disease with the ankle-brachial index: déjà vu all over again (2018) (15)
Heparin-associated thrombocytopenia. (1981) (14)
Spontaneous Coronary Artery Dissection (2021) (14)
Ischemic liver dysfunction after elective repair of infrarenal aortic aneurysm: incidence and outcome. (1998) (13)
Nonatherosclerotic arterial disease of the extracranial cerebrovasculature. (2000) (13)
Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia (2020) (13)
GENERALIZED NON‐LANGERHANS CELL HISTIOCYTOSIS: FOUR CASES ILLUSTRATE A SPECTRUM OF DISEASE (1995) (13)
Are anticardiolipin antibodies really important in thromboangiitis obliterans (Buerger’s disease)? (2002) (12)
Thrombolytic therapy in the treatment of peripheral arterial occlusions. (1988) (12)
Renal Artery Disease (2003) (12)
Rupture of the renal artery nine days after percutaneous transluminal angioplasty. (1987) (12)
Thromboangiitis Obliterans: 110 Years Old and Little Progress Made (2018) (12)
Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study (2010) (12)
chapter 22 – Renal Artery Stenosis: Clinical Evaluation (2006) (11)
Atheroembolic renal disease: Underdiagnosed and misunderstood (2007) (11)
Carotid Artery Pseudo-occlusion: Does End-diastolic Velocity Suggest Need for Treatment? (2009) (11)
Infected pseudoaneurysm at the site of an iliac artery Palmaz stent: Case report and review (1994) (11)
Association of Multifocal Fibromuscular Dysplasia in Elderly Patients With a More Benign Clinical Phenotype: Data From the US Registry for Fibromuscular Dysplasia (2018) (10)
A rare case of familial carotid body tumor in a patient with bilateral fibromuscular dysplasia. (2010) (10)
Atherosclerotic renovascular disease: clinical clues and natural history. (1997) (10)
Atherosclerotic stenosis of the renal arteries. Indications for intervention. (1998) (10)
Updates in Spontaneous Coronary Artery Dissection (2020) (10)
Correlation between noninvasive and endovascular Doppler in patients with atherosclerotic renal artery stenosis: A pilot study (2006) (10)
2-Microglobulin as a Biomarker in Peripheral Arterial Disease: Proteomic Profiling and Clinical Studies” (2007) (9)
Task force 11: Training in vascular medicine and peripheral vascular catheter‐based interventions: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Vascular Medicine (2008) (9)
Renal denervation for resistant hypertension: not dead yet. (2014) (9)
Internal Medicine Interns Have a Poor Knowledge of Peripheral Artery Disease (2012) (9)
Advances in noninvasive screening for renovascular disease. (1994) (9)
Heparin Administration via Nomogram versus a Standard Approach in Venous and Arterial Thromboembolic Disease (1996) (9)
Hypertension and peripheral arterial disease. (2005) (8)
Diseases of the aorta (1992) (8)
Thrombolytic therapy for renal artery occlusions: a preliminary report. (1989) (8)
Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia. (2021) (8)
Duplex ultrasonography and its impact on providing endograft surveillance. (2003) (8)
Misconceptions about the diagnosis and treatment of fibromuscular dysplasia (2009) (8)
Images in vascular medicine (2006) (7)
Fibromuscular dysplasia. (2012) (7)
Clinical associations of headaches among patients with fibromuscular dysplasia: A Report from the US Registry for Fibromuscular Dysplasia (2020) (7)
Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: (2015) (7)
2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions) (2021) (7)
ANEURYSM AND DISSECTION IN FIBROMUSCULAR DYSPLASIA: FINDINGS FROM THE UNITED STATES REGISTRY FOR FMD (2014) (7)
Fibromuscular Dysplasia: Looking Beyond the "String of Beads". (2017) (7)
Thrombolytic therapy. A review (Part 1 of 2). (1989) (6)
Physical activity and exercise in patients with spontaneous coronary artery dissection and fibromuscular dysplasia. (2021) (6)
The Top 12 Advances in Vascular Medicine (2004) (6)
How to use low-molecular weight heparin for outpatient management of deep vein thrombosis. (1999) (6)
Atherosclerotic renovascular disease: diagnosis and management. (1990) (6)
Images in vascular medicine (2007) (6)
Syndromes that mimic vasculitis (1991) (6)
UNRAVELING PULSATILE TINNITUS IN FMD: A REPORT OF THE UNITED STATES REGISTRY FOR FIBROMUSCULAR DYSPLASIA (2014) (5)
Pulmonary Embolism (2002) (5)
Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41)) (2015) (5)
Association Task Force on Practice Guidelines Report of the American College of Cardiology Foundation/American Heart Patients With Peripheral Artery Disease (Updating the 2005 Guideline) : A 2011 ACCF/AHA Focused Update of the Guideline for the Management of (2011) (5)
Presidential address (2001) (5)
Re: Carotid artery fibromuscular dysplasia. (2007) (5)
Lowering cholesterol in high risk individuals and populations (1996) (5)
Role of the cardiologist in peripheral vascular disease. (1992) (5)
Unsupervised Learning for Automated Detection of Coronary Artery Disease Subgroups (2021) (5)
Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months (2009) (5)
Standing waves are not fibromuscular dysplasia. (2012) (5)
Long-term outcomes and cost-effectiveness of screening for abdominal aortic aneurysm (2007) (5)
Society for Vascular Medicine and Biology: a vision for the future. (2000) (5)
Serpentine supravenous hyperpigmentation due to hydroxychloroquine (2016) (5)
Fibromuscular dysplasia [3] (2004) (5)
Lipid and lipoprotein abnormalities in lower-extremity arteriosclerosis obliterans. (1992) (5)
A teenager with mixed connective tissue disease presenting with an acute coronary syndrome (2004) (4)
Cardiovascular manifestations of hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders (2022) (4)
Exercise-induced leg pain and high blood pressure. (2014) (4)
Case report: acute thrombotic occlusion and pseudoaneurysm of the brachial artery diagnosed by Doppler ultrasound after nondiagnostic angiography (2013) (4)
Superior Myocardial Protection Using “ Polarizing ” Adenosine , Lidocaine , and Mg 2 þ Cardioplegia in Humans (2016) (4)
MORBIDITY, VASCULAR EVENTS AND INTERVENTIONAL THERAPY FOR FIBROMUSCULAR DYSPLASIA: A REPORT OF THE FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY (2011) (4)
Abstract 15370: Genetic Study Identifies Common Variation in PHACTR1 to Associate With Fibromuscular Dysplasia (Best of Basic Science Abstract) (2015) (4)
Duplex Scanning of Renal Arteries for Stenosis (1996) (4)
Is vascular medicine a viable specialty? (2001) (4)
Focal and multifocal renal artery fibromuscular dysplasia. (2019) (4)
Male Sex Is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia (2021) (4)
The Society for Vascular Medicine: The first quarter century (2015) (4)
80 – Other Peripheral Arterial Diseases (2012) (4)
CLINICAL FEATURES AND PRESENTING SYMPTOMS AND SIGNS OF FIBROMUSCULAR DYSPLASIA: A REPORT OF THE FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY (2011) (4)
Letter by Kadian-Dodov and Olin Regarding Article, "Embolic Stroke of Undetermined Source and Symptomatic Nonstenotic Carotid Disease". (2020) (4)
2020 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee. (2020) (4)
Angina and coronary ostial lesions in a young woman as a presentation of Takayasu's arteritis. (1999) (3)
Can functional performance be used as a simple prognostic indicator in peripheral arterial disease? (2008) (3)
Thrombolytic therapy. A review (2). (1989) (3)
Exclusion of Persons with Kidney Disease in Trials of Peripheral Artery Disease: A Systematic Review of Randomized Trials. (2019) (3)
Abstract 099: Prevalence of Headaches in Patients with Fibromuscular Dysplasia: A Report from the US Registry for FMD (2017) (3)
PERIPHERAL ARTERY DISSECTION IN PATIENTS WITH FIBROMUSCULAR DYSPLASIA: A REPORT FROM THE UNITED STATES FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY (2012) (3)
Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic (2021) (3)
An algorithmic approach to peripheral artery disease in hemophilia: extrapolation of management principles from noncoagulopathic patients (2012) (3)
Peripheral Vascular Disease (2002) (2)
Survival in atherosclerotic renal artery stenosis: Its all about renal function, or is it? (2007) (2)
VORAPAXAR REDUCES PERIPHERAL REVASCULARIZATION REGARDLESS OF THE NUMBER OF DISEASED TERRITORIES: INSIGHTS FROM THE TRA2P–TIMI 50 TRIAL (2013) (2)
Pushing Pause on the Paclitaxel Debate: Applying Appropriate Scientific Inquiry and Publication Processes to Inform Clinical Decision-Making. (2019) (2)
PREVALENCE OF ARTERIAL ANEURYSMS IN PATIENTS WITH FIBROMUSCULAR DYSPLASIA: A REPORT FROM THE UNITED STATES REGISTRY FOR FIBROMUSCULAR DYSPLASIA (2013) (2)
Is Spontaneous Rupture of Aortic Plaques Truly More Common Than Believed? (2018) (2)
Images in vascular medicine (2003) (2)
Antihypertensive treatment in patients with peripheral vascular disease. (1994) (2)
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer. (2020) (2)
Renal artery stenosis (1999) (2)
Cholesterol lowering: perspectives on the 4S and West of Scotland studies. (1996) (2)
Incomplete (Latent) Subclavian Steal Syndrome (1997) (2)
Does Vitamin D Have a Role in Reducing the Risk of Peripheral Artery Disease?–Reply–I (2010) (2)
Guidelines for a training program in vascular medicine: A position paper from the Society for Vascular Medicine and Biology (1994) (2)
Association of Fibromuscular Dysplasia and Pulsatile Tinnitus: A Report of the US Registry for Fibromuscular Dysplasia (2021) (2)
Lower-extremity arterial disease: tips on diagnosis and therapy. (1993) (2)
Antithrombotic Therapy to Reduce Mortality in Patients With Atherosclerosis: 2 Pathways to a Single Goal. (2021) (2)
PHYSICAL EXAMINATION FINDINGS IN FIBROMUSCULAR DYSPLASIA: A REPORT OF THE UNITED STATES REGISTRY FOR FIBROMUSCULAR DYSPLASIA (2012) (2)
Antiplatelet therapy: a vascular medicine perspective. (2000) (2)
Thromboembolic disease: underdiagnosed, undertreated, deadly. (1994) (2)
Chapter 23 – Clinical Evaluation of Renal Artery Disease (2013) (1)
Abstract 12390: Understanding Patient Characteristics and Clinical Significance of Headaches in Patients With Fibromuscular Dysplasia: A Report of the United States Registry for Fibromuscular Dysplasia (2013) (1)
Clinical pathological conference: a 51-year-old man with a history of stroke and red streaks in the legs. (1994) (1)
Clinical Clues to the Diagnosis of PAD (2003) (1)
Clinical Vascular Medicine (2003) (1)
Long-term safety and efficacy of intramuscular administration of Cl-1023 (AdGVVEGF121.10) in patients with intermittent claudication (2002) (1)
Vascular Function in Fibromuscular Dysplasia (2015) (1)
1046-165 Measurement of resting ankle branchial index may not accurately identify disease in patients with signs or symptoms of peripheral arterial disease (2004) (1)
RARE LOSS-OF-FUNCTION MUTATIONS OF PTGIR IDENTIFIED IN FIBROMUSCULAR DYSPLASIA AND SPONTANEOUS CORONARY ARTERY DISSECTION (2019) (1)
DIAGNOSTIC UTILITY OF CAROTID ARTERY ULTRASOUND FOR THE PRIMARY INDICATION OF SYNCOPE (2014) (1)
Spontaneous compartment syndrome and endovascular repair of tibioperoneal trunk pseudoaneurysm in Ehlers-Danlos syndrome (2021) (1)
RESPONSE: Do Pulmonary Embolism Response Teams Result in Improved Outcomes in Patients With Pulmonary Embolism? (2021) (1)
A 56-year-old woman with syncope, chest pressure, and exertional dyspnea. (1995) (1)
The CREST-2 Registry: First Glimpse at a Carotid Stenting Comeback? (2019) (1)
Renal artery stenting for control of congestive heart failure (1994) (1)
Renal and Mesenteric Artery Disease (2008) (1)
Efficacy and Safety of Vorapaxar by Intensity of Background Lipid‐Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P‐TIMI 50 Trial (2021) (1)
Images in vascular ultrasound (2002) (1)
SVM Communications: Membership spotlight (2021) (1)
The Difficulty of Determining Disease Activity in Large Artery Vasculitis. (2017) (1)
The Fate of Life and Limb After Peripheral Artery Revascularization. (2020) (1)
chapter 44 – Thromboangiitis Obliterans (Buerger's Disease) (2006) (1)
Abstract 17062: Plasma Asymmetric Dimethylarginine Levels Correlate with Peripheral Arterial Disease Severity but not Coronary Artery Disease (2012) (0)
Presidential address (2000) (0)
Author Correction: Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases (2022) (0)
UNDER PRESSURE: UTILIZING ULTRASOUND GUIDED COMPRESSION FOR TREATMENT OF FEMORAL ARTERY PSEUDOANEURYSM IN A NEWBORN WITH CONGENITAL HEART DISEASE (2023) (0)
Images in vascular medicine (1999) (0)
Abstract 145: Differences in Presenting Symptoms of Fibromuscular Dysplasia Patients With Family History of Fibromuscular Dysplasia, Arterial Aneurysm, Dissection, or Sudden Death: A Report from the United States Registry for Fibromuscular Dysplasia (2016) (0)
Abstract 3076: Low Lifetime Recreational Activity is a Risk Factor for Peripheral Arterial Disease (2008) (0)
What is the optimal treatment for mild/moderate hypertension? (1992) (0)
Atherosclerosis reviews (vol 21): prevention and noninvasive therapy of atherosclerosis (1993) (0)
Atherosclerotic Renovascular Disease: Clinical Clues and Natural History (1997) (0)
Reversible renal insufficiency and angiotensin-converting enzyme inhibitor therapy. (1992) (0)
Re: The American "board" of vascular medicine: questions and concerns. (2006) (0)
Lipoprotein abnormalities in patients with lower extremity arteriosclerosis obliterans (1990) (0)
Diagnosis and treatment of lower-extremity arteriosclerosis. (1989) (0)
Images in vascular ultrasound (2005) (0)
Professor Gale's Sound and Well-Balanced Wine (1978) (0)
The clinical evaluation and noninvasive diagnosis of atherosclerotic renal artery stenosis (1999) (0)
Abstract 3631: Plasma Asymmetric Dimethylarginine is an Independent Marker of Peripheral Artery Disease but not Coronary Artery Disease: A Novel Marker of Atherosclerosis with Topographical Specificity (2006) (0)
Arteriovenous fistula from the common carotid artery to the internal jugular vein (1999) (0)
Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease. (2022) (0)
Meetings Calendar (1991) (0)
Rupture of the Renal Artery After Percutaneous Transluminal Angioplasty-Reply (1987) (0)
Asymmetric Dimethylarginine (ADMA) levels correlate with peripheral vascular disease severity but not coronary artery disease (2012) (0)
Regarding the Case of Postpartum Sudden Cardiac Death After Spontaneous Coronary Artery Dissection in a Patient With Fibromuscular Dysplasia (2018) (0)
Comment on: Carotid artery fibromuscular dysplasia (2007) (0)
Treating high cholesterol: everyday applications of the national guidelines. (1991) (0)
Antiplatelet therapy: a vascular medicine perspective. (2000) (0)
ACC/AHA Aortic Disease Guidelines: What Was Simple Is Now Complex-Moving to Multidisciplinary Teams, Specialized Centers. (2022) (0)
A mimic of vasculitis. (1992) (0)
Thoracic Endovascular Aortic Repair is a Viable Option for Progressive Large Vessel Vasculitis (2023) (0)
Abstract 3901: Young Patients Infected with Human Immunodeficiency Virus Have Increased Prevalence of Peripheral Arterial Disease (2006) (0)
Contemporary Issues in Peripheral Vascular Disease (1993) (0)
Metabolic consequences of antihypertensive therapy (1987) (0)
Remembering Jess R Young, MD, MSVM (1928–2021): SVM Founding Member and First President (2022) (0)
Images in vascular ultrasound (2003) (0)
Inflammatory Diseases of the Aorta: JACC Focus Seminar, Part 2. (2022) (0)
Antiplatelet pathways development. Panel discussion. (2000) (0)
Abstract 121: Anxiety and Depression in Patients With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia (2018) (0)
Evaluation and Treatment of Patients With Lower Extremity Peripheral ArteryDisease (2015) (0)
Atherosclerotic Vascular Diseases:: Should Nationwide Programs Be Instituted? Atherosclerotic Peripheral Vascular Disease Symposium II: Screening for (2009) (0)
The Society for Vascular Medicine and Biology (1999) (0)
Renal Denervation for Resistant Hypertension (2014) (0)
Images in vascular medicine. Incomplete (latent) subclavian steal syndrome. (1997) (0)
A Case 1 : A 34-year-old woman with hypertension (2007) (0)
Abstract 13108: Socioeconomic Barriers to the Diagnosis of Peripheral Arterial Disease (2013) (0)
Spontaneous Coronary Artery Dissection: Lower Than Expected Recurrence Rate in a Large Prospective Canadian Cohort. (2022) (0)
VASCULAR FINDINGS IN PATIENTS WITH CERVICAL ARTERY DISSECTION IN THE PRESENCE OR ABSENCE OF FIBROMUSCULAR DYSPLASIA (2021) (0)
Antiphospholipid antibodies, antiphospholipid syndromes and atherosclerosis of the large lower extremity (LE) arteries: a clinical observation (1994) (0)
Common Genetic Variant in PHACTR1/EDN1 Locus Is Associated with Spontaneous Coronary Artery Dissection Brief title: genetic variant rs9349379 associates with SCAD (2019) (0)
GENOME-WIDE ASSOCIATION STUDY OF PERIPHERAL ARTERY DISEASE AND CAROTID ARTERY DISEASE IDENTIFIES NOVEL GENETIC LOCI AND COAGULATION PATHWAYS (2020) (0)
Abstract 3080: Sex Differences in Peripheral Arterial Disease (2008) (0)
Reviews and Notes: Cardiology and Angiology: Vascular Medicine: A Textbook of Vascular Biology and Diseases (1994) (0)
Abstract 19102: Association between Smoking and the Natural History of Renal and Cerebrovascular Fibromuscular Dysplasia: a Report of the United States Registry for FMD (2014) (0)
DIAGNOSTIC AND FOLLOW-UP IMAGING FOR FIBROMUSCULAR DYSPLASIA: A REPORT FROM THE UNITED STATES FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY (2012) (0)
Renovascular Disease: When and How To Treat (2003) (0)
2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions) (2021) (0)
chapter 51 – Pernio (Chilblains) (2006) (0)
Paradoxical thromboembolism associated with heparin therapy. A case report and review of the literature. (1981) (0)
Abstract 14653: Genome-wide Association Study of Peripheral Artery Disease and Critical Limb Ischemia Identifies Novel Genetic Loci and Coagulation Pathways (2020) (0)
Response to Letter Regarding Article, “β2-Microglobulin as a Biomarker in Peripheral Arterial Disease: Proteomic Profiling and Clinical Studies” (2008) (0)
DUPLEX SCANNING OF RENAL ARTERIES FOR STENOSIS. AUTHORS' REPLY (1996) (0)
Reduced Ankle Brachial Index is Associated with Adverse Long Term Prognosis in Patients Referred for Coronary Angiogram (2007) (0)
Reply: Endovascular-First Treatment of Peripheral Arterial Disease Remains Controversial. (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jeffrey W. Olin?

Jeffrey W. Olin is affiliated with the following schools:

Jeffrey W. Olin's Academic­Influence.com Rankings

Why Is Jeffrey W. Olin Influential?

Jeffrey W. Olin's Published Works

Published Works

What Schools Are Affiliated With Jeffrey W. Olin?

Jeffrey W. Olin's AcademicInfluence.com Rankings